We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$4.11B
AUM Growth
+$122M
Cap. Flow
-$44.5M
Cap. Flow %
-1.08%
Top 10 Hldgs %
25.6%
Holding
358
New
11
Increased
72
Reduced
178
Closed
13

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$4.53M
2
COF icon
Capital One
COF
+$3.35M
3
V icon
Visa
V
+$2.76M
4
MSFT icon
Microsoft
MSFT
+$2.6M
5
MMM icon
3M
MMM
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 20.48%
2 Technology 18.86%
3 Financials 12.39%
4 Consumer Discretionary 10.89%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
26
Automatic Data Processing
ADP
$105B
$44M 1.07%
266,152
-1,523
-0.6% -$247K
MDY icon
27
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$43.6M 1.06%
122,970
+1,407
+1% +$492K
INTC icon
28
Intel
INTC
$460B
$40.4M 0.98%
843,241
-41,578
-5% -$2.06M
EMLP icon
29
First Trust North American Energy Infrastructure Fund
EMLP
$4.09B
$40.1M 0.98%
1,593,710
+25,631
+2% +$637K
RTN
30
DELISTED
Raytheon Company
RTN
$40M 0.97%
230,268
-11,132
-5% -$2M
CVX icon
31
Chevron
CVX
$383B
$39.1M 0.95%
314,552
-4,797
-2% -$580K
META icon
32
Meta Platforms (Facebook)
META
$1.37T
$39M 0.95%
202,125
-2,804
-1% -$512K
PFE icon
33
Pfizer
PFE
$142B
$39M 0.95%
948,137
-10,031
-1% -$398K
MRK icon
34
Merck
MRK
$321B
$38M 0.93%
475,337
-6,487
-1% -$497K
AFL icon
35
Aflac
AFL
$64.8B
$37M 0.9%
675,227
-5,944
-0.9% -$306K
RMD icon
36
ResMed
RMD
$30.3B
$36.9M 0.9%
302,596
-1,639
-0.5% -$182K
CMCSA icon
37
Comcast
CMCSA
$84B
$34.7M 0.85%
821,497
+14,883
+2% +$628K
MMM icon
38
3M
MMM
$90.8B
$34.6M 0.84%
238,695
-16,850
-7% -$2.59M
WFC icon
39
Wells Fargo
WFC
$258B
$33.5M 0.82%
709,031
-36,200
-5% -$1.69M
NVDA icon
40
NVIDIA
NVDA
$4.72T
$32.9M 0.8%
8,008,000
-101,520
-1% -$421K
TJX icon
41
TJX Companies
TJX
$176B
$32.8M 0.8%
620,995
-7,631
-1% -$406K
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$122B
$32.3M 0.79%
175,927
+1,477
+0.8% +$258K
ABBV icon
43
AbbVie
ABBV
$455B
$31.9M 0.78%
438,648
-18,095
-4% -$1.42M
AMP icon
44
Ameriprise Financial
AMP
$48.1B
$31.2M 0.76%
214,692
+1,033
+0.5% +$149K
IRM icon
45
Iron Mountain
IRM
$37.1B
$29.6M 0.72%
946,773
-32,126
-3% -$1.05M
COST icon
46
Costco
COST
$423B
$29.6M 0.72%
112,067
-3,767
-3% -$939K
CHD icon
47
Church & Dwight Co
CHD
$23.1B
$28.7M 0.7%
392,536
+6,008
+2% +$447K
SWK icon
48
Stanley Black & Decker
SWK
$14.9B
$27.8M 0.68%
192,502
-919
-0.5% -$129K
FTV icon
49
Fortive
FTV
$17.7B
$26.7M 0.65%
518,512
+576
+0.1% +$29.9K
GOOGL icon
50
Alphabet (Google) Class A
GOOGL
$4.08T
$26.3M 0.64%
485,980
-5,940
-1% -$344K

Similar funds

Welch & Forbes's Q2 2019 Portfolio in Review

As of Q2 2019, Welch & Forbes held 358 positions worth $4.11B, up 3.1% from $3.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Welch & Forbes's Q2 2019 filing shows 11 new, 72 increased, 178 reduced and 13 closed positions. Its largest new stake was State Street SPDR S&P Dividend ETF: 22,548 shares worth $2.27M. The largest sale was DuPont de Nemours, an estimated $4.53M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

  • Welch & Forbes's largest Q2 2019 buy was State Street SPDR S&P Dividend ETF: 22,548 shares worth $2.27M.
  • Welch & Forbes added most to Arthur J. Gallagher & Co in Q2 2019, an estimated $5.23M increase.
  • Welch & Forbes's biggest Q2 2019 reduction was Capital One, cutting an estimated $3.35M.
  • Welch & Forbes fully exited DuPont de Nemours in Q2 2019, selling an estimated $4.53M.
  • Welch & Forbes's ten largest holdings make up 26% of its $4.11B portfolio in Q2 2019.
  • Welch & Forbes opened 11 new positions and closed 13 in Q2 2019.
  • Welch & Forbes's portfolio value rose 3.1% quarter-over-quarter to $4.11B.

Based on Welch & Forbes's 13F filing for Q2 2019, filed 12 Jul 2019.